Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
DESTINY-PANTUMOUR04
- Status
- RECRUITING
- Phase
- N/A
Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of GV20-0251 in Advanced or Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS)
- Status
- SUSPENDED
- Phase
- NA
MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.
- Status
- RECRUITING
- Phase
- N/A
Real-world Outcomes Among Patients With Melanoma Treated With Neoadjuvant Nivolumab+Relatlimab or Nivolumab+Ipilimumab
- Status
- COMPLETED
- Phase
- N/A
Study of GV20-0251 in Participants With Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The Florida ASCENT Study
- Status
- RECRUITING
- Phase
- NA
Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Evaluate the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocyte in Patients With Refractory Melanoma Who Failed to Immune Checkpoint Inhibitors
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Genetics Branch Eligibility Screening Survey
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
IDOV-Immune for Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients
- Status
- RECRUITING
- Phase
- PHASE2
Exploratory Study of Inhaled Afatinib Dimaleate PK Profile
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
- Status
- RECRUITING
- Phase
- N/A